CASI PHARMACEUTICALS, INC. Operating Lease, Lease Income
CASI PHARMACEUTICALS, INC. (CASIF) reported Operating Lease, Lease Income of $0 for the 12-month period ending 2024-12-31, per its 20-F filed 2025-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseLeaseIncome · last filed 2025-03-31
| Period end | Operating Lease, Lease Income 12 month |
|---|---|
| 2024-12-31 | $0.00 20-F · filed 2025-03-31 |
| 2023-12-31 | $0.00 20-F · filed 2025-03-31 |
| 2022-12-31 | $60.00K 20-F · filed 2025-03-31 |
| 2021-12-31 | $148.00K 20-F · filed 2024-03-28 |
| 2020-12-31 | $140.00K 20-F · filed 2023-04-26 |